Wed 25 Nov 2009 | 23:16 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Geron Corp

Geron Corp (GERN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View GERN on other exchanges
As of  25 Nov 2009
5.46USD
Price Change
-0.05
Percent Change
-0.91%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Spink, Katharine 34 2009 Vice President - Operations of Regenerative Medicine Programs
Movahhed, Hassan -- 2009 Vice President - Clinical Operations, Oncology
Lebkowski, Jane 53 2009 Senior Vice President, Chief Scientific Officer-Regenerative Medicine
Kelly Behrs, Melissa 45 2007 Senior Vice President - Therapeutic Development, Oncology
Earp, David 44 2004 Senior Vice President - Business Development, Chief Patent Counsel
Benedetti, Fabio 43 2009 Senior Vice President
Okarma, Thomas 63 1999 President, Chief Executive Officer, Director
Kelsey, Stephen -- 2009 Executive Vice President, Chief Medical Officer - Oncology
Kiley, Thomas 65 1992 Director
Fritzky, Edward 58 1998 Director
Zenner, Patrick 62 2001 Director
Homcy, Charles 60 2005 Director
Eastham, Karin 59 2009 Director
Greenwood, David 57 2004 Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Barkas, Alexander 61 1993 Chairman of the Board